MediPoint: Enteral Stents - South America Forecast and Market Analysis
There are three key players in the international enteral stents market. Boston Scientific is the leading company in the enteral stents market thanks to an extensive product line and a presence in all segments of the enteral stents market. Its presence was further strengthened by the acquisition of EndoChoice, a former smaller player in the enteral stents market. The other two key players in the enteral stents market are Cook Medical and Taewoong Medical. Cook Medical has established a strong presence despite a small product line, while Taewoong Medical has a more extensive product portfolio.
Enteral stents are a palliative treatment option for constrictions caused primarily by various cancers. The primary cancers which cause constrictions requiring the use of enteral stents are esophageal cancer, gastric cancer, pancreatic cancer, and colorectal cancer. There are three primary enteral stents; the covered enteral stent, the partially covered enteral stents, and the non-covered enteral stent.
The South American market for enteral stents, which encompasses three countries and includes esophageal stents, gastrointestinal stents, and colonic stents, was valued at approximately $7.8M in 2016. The market is expected to grow at a CAGR of 4.2%, to reach a valuation of $10.3M in 2023.
The key drivers of this market during the forecast period are -